Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Vera, E. Mincholé, M. A. Ruiz, A. B. Lasierra, B. Moles, N. Peyman-Fard, M. J. Revillo, S. Bello (Zaragoza, South Africa; Zaragoza, Spain). Viral and mixed virus-bacteria community-acquired pneumonia (CAP) in hospitalized adults. Eur Respir J 2009; 34: Suppl. 53, 2415

Member's Comments

No comment yet.

Related content which might interest you: Role of viruses, alone and in association with bacteria, in adults hospitalized with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Mixed community-acquired pneumonia in hospitalised patients Source: Eur Respir J 2006; 27: 795-800 Year: 2006 Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Role of virus in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Etiology of community-acquired pneumonia (CAP) in young hospital patients Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002 The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Biomarkers in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Corticosteroids and community-acquired pneumonia Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia Source: Annual Congress 2007 - Infections year in review Year: 2007 Detection parachlamydia acanthamoeba and simkania negevensis in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004 Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients Source: Annual Congress 2011 - COPD management Year: 2011 Clinical significance of virus detected community-acquired pneumonia in adults Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Management of community-acquired pneumonia in adult outpatients Source: Eur Respir J 2006; 28: Suppl. 50, 377s Year: 2006 Community-acquired pneumonia (CAP) with cytomegaloviral (CMV) persistence at young adults: prevalence and reciprocal burdening Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 Virological diagnosis in community-acquired pneumonia in immunocompromised patients Source: Eur Respir J 2008; 31: 618-624 Year: 2008 One year analysis of hospital-treated, community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002 Bacterial infections and community-acquired pneumonia in children Source: Annual Congress 2011 - Paediatric Year in Review Year: 2011 Epidemiology of community-acquired pneumonia (CAP) Source: International Congress 2015 – Russia Day: Community-acquired pneumonia (CAP) in adults Year: 2015